Este relatório examina o potencial da IA na descoberta de medicamentos, explorando as principais aplicações, avaliando a maturidade, identificando barreiras e propondo soluções. Ele enfatiza o papel crucial dos financiadores de pesquisa em saúde na formação desse campo dinâmico para atender às necessidades urgentes de saúde de forma equitativa.
Educação
- MBA, Harvard Business School
- BA, Governo, Summa cum laude e Phi beta kappa, Dartmouth College
Andrew Rodriguez is a core member of the Health Care, Strategy, and Corporate Development practices at Boston Consulting Group.
Since joining BCG in 2002, Andrew has acquired broad health care experience in multiple sectors, focusing on biopharmaceuticals, vaccines, and global health. His clients have included multinational companies, foundations, and international organizations. As a core member of the firm’s global-health team, he has worked extensively on a range of assignments with the Bill & Melinda Gates Foundation.
Before joining BCG, Andrew was a strategic-planning manager with the worldwide beverage-company Diageo and cofounder of the business accelerator Techwell.
